Patents by Inventor Michael Jerosch-Herold

Michael Jerosch-Herold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and apparatus for noninvasive quantitative detection of fibrosis in normal and viable myocardium by MRI
    Patent number: 10076246
    Abstract: Embodiments provide a noninvasive quantitative method for detecting extent and/or types of fibrosis in the heart. In embodiments, information pertaining to the extent and/or types of fibrosis may aid in the diagnosis of specific cardiac diseases and heart failure and/or may assist in determining suitable treatment options. Embodiments provide methods and apparatuses for determining the extent of fibrosis in viable and nonviable myocardium, which may then be correlated to heart disease and failure. Thus, in an embodiment, a method of screening individuals for the purpose of heart disease or heart failure prevention may be provided using the detection methodology described herein.
    Type: Grant
    Filed: June 5, 2013
    Date of Patent: September 18, 2018
    Assignee: Oregon Health & Science University
    Inventors: Michael Jerosch-Herold, Sumeet S. Chugh
  • METHOD AND APPARATUS FOR NONINVASIVE QUANTITATIVE DETECTION OF FIBROSIS IN THE HEART
    Publication number: 20130267828
    Abstract: Embodiments provide a noninvasive quantitative method for detecting extent and/or types of fibrosis in the heart. In embodiments, information pertaining to the extent and/or types of fibrosis may aid in the diagnosis of specific cardiac diseases and heart failure and/or may assist in determining suitable treatment options. Embodiments provide methods and apparatuses for determining the extent of fibrosis in viable and nonviable myocardium, which may then be correlated to heart disease and failure. Thus, in an embodiment, a method of screening individuals for the purpose of heart disease or heart failure prevention may be provided using the detection methodology described herein.
    Type: Application
    Filed: June 5, 2013
    Publication date: October 10, 2013
    Applicant: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Michael Jerosch-Herold, Sumeet S. Chugh
  • MAPC generation of muscle
    Patent number: 8252280
    Abstract: The present invention relates to methods of increasing function and/or mass in damaged striated muscle tissue of interest (e.g., cardiac or muscle tissue) by providing of a population of multipotent adult progenitor cells (“MAPCs”), which effectively generate new striated muscle over time.
    Type: Grant
    Filed: May 11, 2011
    Date of Patent: August 28, 2012
    Assignee: Regents of the University of Minnesota
    Inventors: Catherine M. Verfaillie, Robert Gallegos, Michael Jerosch-Herold
  • METHOD AND APPARATUS FOR NONINVASIVE QUANTITATIVE DETECTION OF FIBROSIS IN THE HEART
    Publication number: 20100129292
    Abstract: Embodiments provide a noninvasive quantitative method for detecting extent and/or types of fibrosis in the heart. In embodiments, information pertaining to the extent and/or types of fibrosis may aid in the diagnosis of specific cardiac diseases and heart failure and/or may assist in determining suitable treatment options. Embodiments provide methods and apparatuses for determining the extent of fibrosis in viable and nonviable myocardium, which may then be correlated to heart disease and failure. Thus, in an embodiment, a method of screening individuals for the purpose of heart disease or heart failure prevention may be provided using the detection methodology described herein.
    Type: Application
    Filed: April 11, 2008
    Publication date: May 27, 2010
    Applicant: Oregon Health & Science University
    Inventors: Michael Jerosch-Herold, Sumeet S. Chugh
  • Determination of fluid transport properties in porous media by nuclear magnetic resonance measurements of fluid flow
    Patent number: 5428291
    Abstract: The present invention is a method to determine fluid transport properties of porous media by nuclear magnetic resonance measurements of fluid flow. The NMR signal is encoded by the fluid flow velocity from which the velocity spectrum and the fluid flow properties are obtained.
    Type: Grant
    Filed: July 1, 1993
    Date of Patent: June 27, 1995
    Assignee: Exxon Research and Engineering Company
    Inventors: Hans Thomann, Michael Jerosch-Herold
  • Permeability determination from NMR relaxation measurements for fluids in porous media
    Patent number: 5387865
    Abstract: The present invention is a method to rapidly determine the fluid-flow permeability of porous media with nuclear magnetic resonance (NMR). The method can be applied to measurements of permeability in fluid-saturated earth formations using NMR logging tools.
    Type: Grant
    Filed: March 11, 1993
    Date of Patent: February 7, 1995
    Assignee: Exxon Research and Engineering Company
    Inventors: Michael Jerosch-Herold, Hans Thomann
  • Permeability determination from NMR relaxation measurements for fluids in porous media
    Patent number: 5289124
    Abstract: The present invention is a method to rapidly determine the fluid-flow permeability of porous media with nuclear magnetic resonance (NMR). The method can be applied to measurements of permeability in fluid-saturated earth formations using NMR logging tools.
    Type: Grant
    Filed: September 20, 1991
    Date of Patent: February 22, 1994
    Assignee: Exxon Research and Engineering Company
    Inventors: Michael Jerosch-Herold, Hans Thomann